Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies.

Autor: Fagnano E; Targeted Therapy Group, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom., Pendharkar S; Targeted Therapy Group, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom., Colton M; Targeted Therapy Group, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom., Jones PN; Targeted Therapy Group, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom., Sallan MC; Centre for Haemato-Oncology, John Vane Science Centre, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Klymenko T; Department of Biosciences and Chemistry, Sheffield Hallam University, Sheffield, United Kingdom., Braun A; Centre for Haemato-Oncology, John Vane Science Centre, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Klein C; Roche Innovation Center Zurch, Roche Glycart AG, Schlieren, Switzerland., Honeychurch J; Targeted Therapy Group, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom., Cheadle EJ; Targeted Therapy Group, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom., Illidge TM; Targeted Therapy Group, Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.

Publikováno v: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2023 Oct 31; Vol. 11, pp. 1270398. Date of Electronic Publication: 2023 Oct 31 (Print Publication: 2023).